Search results
15 paź 2020 · With this consensus statement, the EAN provides neurologists with structured recommendations based on broad consensus for good clinical practice in the care of patients with neurological diseases during the COVID-19 pandemic.
1 sie 2024 · In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the coronavirus disease 2019 (COVID-19) pandemic was published.
10 lut 2022 · Discover: Part 1 presents a review of epidemiology, pathophysiology and diagnosis of COVID-19 and CV conditions in patients with COVID-19; Part 2 covers care pathways, including triage, diagnosis, treatment (medical and interventions) and follow-up of patients with CVD in this scenario.
The inclusion criteria are: (1) CPGs and expert consensus statements of rehabilitation for COVID-19 issued by nationally or internationally recognised government authorities, medical/academic societies or organisations; (2) CPGs and expert consensus statements focusing on patients with COVID-19.
30 maj 2023 · Factsheet on the COVID-19 pathogen, surveillance, clinical features, epidemiology, transmission, case management, and public health control measures.
EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol. 2021 Jan;28 (1):7-14. doi: 10.1111/ene.14521. Epub 2020 Oct 15. Authors.
1 paź 2022 · A 2021 European multicenter, prospective cohort study included 4244 adults with severe and critical COVID-19 and showed that 11% (235/2153) of patients with critical COVID-19 received ECMO therapy. [153]
